«Radioimmunodetection

Below is an extended Radioimmunodetection patents listing. Click here to return to the Radioimmunodetection main in depth entry.

Patents :
US Patent No.	Title
7052872	Bi-specific antibodies for pre-targeting diagnosis and therapy
7183076	Method for making multispecific antibodies having heteromultimeric and common components
7183388	Anti-MUC-1 single chain antibodies for tumor targeting
7195750	Clinical parameters for determining hematologic toxicity prior to radioimmunotherapy
7201890	Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy
7214368	Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-.alpha. transgene
7220399	Alpha or beta emitters attached to fragments in radioimmunotherapy
7223380	Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
7229604	Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
7230085	Anti-DOTA antibody
7232888	Antibodies against tumor surface antigens
7173125	Triphosphate oligonucleotide modification reagents and uses thereof
7172751	D-amino acid peptides
7163680	Treatment and diagnosis of cancer
7067111	Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
7074403	Immunotherapy of autoimmune disorders using antibodies which target B-cells
7074405	Use of bi-specific antibodies for pre-targeting diagnosis and therapy
7102024	Functional biopolymer modification reagents and uses thereof
7112317	Combined methods and compositions for tumor vasculature targeting and tumor treatment
7112412	Treatment and diagnosis of prostate cancer
7125541	Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy
7135182	Inhibition of transglutaminase-mediated microbial interaction with a mammalian host
7138103	Use of bi-specific antibodies for pre-targeting diagnosis and therapy
7147856	Stable radioiodine conjugates and methods of their synthesis
7238775	Receptor(SSTR4)-selective somatostatin analogs
7238785	RS7 antibodies
7348419	Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications
7373197	Methods and devices to expand applications of intraoperative radiation probes
7381560	Expression and use of anti-CD20 antibodies
7387772	Chimeric, human and humanized anti-CSAP monoclonal antibodies
7390635	Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
7405320	Therapeutic and diagnostic conjugates for use with multispecific antibodies
7412279	Systems and methods for targeted magnetic resonance imaging of the vascular system
7413736	Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications
7414121	Chimeric, human and humanized anti-CSAp monoclonal antibodies
7422739	Anti-CD20 antibodies
7344715	Method for treating multiple myeloma
7335744	Prostate cancer specific internalizing human antibodies
7332585	Bispecific single chain Fv antibody molecules and methods of use thereof
7247302	Method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis
7259249	Method for preparing conjugates of proteins and chelating agents
7261875	Dendritic poly (amino acid) carriers and methods of use
7279289	Method of evaluating myelosuppressive state
7300644	Targeted combination immunotherapy
7300655	Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
7306783	Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
7306784	Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
7320791	Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules
7332580	Bispecific single chain Fv antibody molecules and methods of use thereof
7429381	Production and use of novel peptide-based agents for use with bi-specific antibodies

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.